NPs Basic Information
|
Name |
Aniduquinolone C
|
| Molecular Formula | C21H23NO4 | |
| IUPAC Name* |
(3S,4S)-4,5-dihydroxy-3-methoxy-6-(3-methylbut-2-enyl)-4-phenyl-1,3-dihydroquinolin-2-one
|
|
| SMILES |
CC(=CCC1=C(C2=C(C=C1)NC(=O)[C@H]([C@@]2(C3=CC=CC=C3)O)OC)O)C
|
|
| InChI |
InChI=1S/C21H23NO4/c1-13(2)9-10-14-11-12-16-17(18(14)23)21(25,15-7-5-4-6-8-15)19(26-3)20(24)22-16/h4-9,11-12,19,23,25H,10H2,1-3H3,(H,22,24)/t19-,21+/m1/s1
|
|
| InChIKey |
DRIVJEVMJVKUHC-CTNGQTDRSA-N
|
|
| Synonyms |
Aniduquinolone C; CHEMBL2431782
|
|
| CAS | NA | |
| PubChem CID | 72703462 | |
| ChEMBL ID | CHEMBL2431782 |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 353.4 | ALogp: | 3.0 |
| HBD: | 3 | HBA: | 4 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 78.8 | Aromatic Rings: | 3 |
| Heavy Atoms: | 26 | QED Weighted: | 0.729 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.687 | MDCK Permeability: | 0.00001550 |
| Pgp-inhibitor: | 0.361 | Pgp-substrate: | 0.621 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.051 |
| 30% Bioavailability (F30%): | 0.016 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.754 | Plasma Protein Binding (PPB): | 96.07% |
| Volume Distribution (VD): | 0.897 | Fu: | 3.52% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.109 | CYP1A2-substrate: | 0.279 |
| CYP2C19-inhibitor: | 0.333 | CYP2C19-substrate: | 0.768 |
| CYP2C9-inhibitor: | 0.361 | CYP2C9-substrate: | 0.619 |
| CYP2D6-inhibitor: | 0.139 | CYP2D6-substrate: | 0.275 |
| CYP3A4-inhibitor: | 0.109 | CYP3A4-substrate: | 0.782 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 5.844 | Half-life (T1/2): | 0.217 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.285 |
| Drug-inuced Liver Injury (DILI): | 0.797 | AMES Toxicity: | 0.455 |
| Rat Oral Acute Toxicity: | 0.287 | Maximum Recommended Daily Dose: | 0.117 |
| Skin Sensitization: | 0.757 | Carcinogencity: | 0.054 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
| Respiratory Toxicity: | 0.364 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002377 |  |
0.733 | D09LDR |  |
0.344 | ||
| ENC002862 |  |
0.638 | D0P3JU |  |
0.340 | ||
| ENC002969 |  |
0.598 | D0E0OG |  |
0.310 | ||
| ENC002966 |  |
0.594 | D0E3OF |  |
0.305 | ||
| ENC002861 |  |
0.563 | D08UMH |  |
0.301 | ||
| ENC002967 |  |
0.552 | D0E4DW |  |
0.296 | ||
| ENC004649 |  |
0.536 | D0QV5T |  |
0.294 | ||
| ENC004800 |  |
0.433 | D0Y7RW |  |
0.293 | ||
| ENC002863 |  |
0.432 | D0J5YC |  |
0.291 | ||
| ENC002453 |  |
0.404 | D07RGW |  |
0.289 | ||